Nicaise Claude

Nicaise Claude is listed in filings as Director at Sarepta Therapeutics, Inc.. This profile follows SEC Form 4 activity through Jun 5, 2026, including sale activity. Recent filings connect the profile to Sarepta Therapeutics, Inc. (SRPT), Gain Therapeutics, Inc. (GANX), and Cassava Sciences, Inc. (SAVA). The current snapshot covers public activity from Jun 26, 2024 to Jun 5, 2026. Reported amounts are shown as $144.0K to $26.9K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.